Table 2 Comparison between group I (Newly diagnosed/Relapsed) and group II (In remission)
Parameter | Group I n = 30 | Group II n = 30 | p-value | Significance | |
|---|---|---|---|---|---|
Age (years) | Mean ± SD | 56.43 ± 8.60 | 53.43 ± 10.22 | 0.224 | NS# |
Gender n (%) | Male | 15 (50) | 21 (70) | 0.114 | NS* |
Female | 15 (50) | 9 (30) | |||
Bone aches n (%) | Yes | 28 (93.3) | 10 (33.3) | 0.000 | HS* |
No | 2 (6.7) | 20 (66.7) | |||
Anemic symptoms n (%) | Yes | 28 (93.3) | 11 (36.7) | 0.000 | HS* |
No | 2 (6.7) | 19 (63.3) | |||
Renal impairment n (%) | Yes | 10 (33.3) | 4 (13.3) | 0.067 | NS* |
No | 20 (66.7) | 26 (86.7) | |||
International staging system n (%) | I | 5 (16.7) | 26 (86.7) | 0.000 | HS* |
II | 8 (26.6) | 4 (13.3) | |||
III | 17 (56.7) | 0 | |||
TLC (X103/μl) | Mean ± SD | 6.97 ± 3.03 | 5.64 ± 1.82 | 0.043 | S# |
Hb (g/dl) | Mean ± SD | 9.47 ± 1.63 | 12.16 ± 1.67 | 0.000 | HS# |
PLT (X103/μl) | Mean ± SD | 228.03 ± 109.70 | 261.90 ± 105.71 | 0.228 | NS# |
Serum albumin (g/dl) | Mean ± SD | 2.91 ± 0.40 | 3.79 ± 0.39 | 0.000 | HS# |
M band (g/dl) n (%) | Absent | 0 (0) | 12 (40) | 0.000 | HS* |
Present | 30 (100) | 18 (60) | |||
S.creatinine (mg/dl) | Median (IQR) | 2.95 (0.95–6.3) | 0.9 (0.8–1.1) | 0.011 | S** |
β2 microglobulin (mg/L) | Median (IQR) | 5.7 (3.9–10.5) | 2.5 (2.1–2.9) | 0.000 | HS** |
BMPCs (%) | Median (IQR) | 55 (30–80) | 3 (1.5–4) | 0.000 | HS** |